1. The effect of a restriction policy on the antimicrobial consumption in Turkey: a country-wide study

   • Salih Hoşoğlu
   • Saban Esen
   • Mustafa Kemal Celen

   Special Article 21 September 2005 Pages: 727 - 731

   

2. Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries

   • Christopher M. H. Newman
   • Ian Starkey
   • William S. Hillis

   Pharmacodynamics 08 September 2005 Pages: 733 - 742

   

3. Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups

   • Kyoung-Ah Kim
   • Sook-Young Lee
   • Ji-Young Park

   Pharmacogenetics 26 August 2005 Pages: 743 - 747

4. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population

   • Marisol López
   • Jorge Guerrero
   • María Elisa Alonso

   Pharmacogenetics 26 October 2005 Pages: 749 - 754

   

5. Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans

   • Tashinga E. Bapiro
   • Jane Sayi
   • Collen M. Masimirembwa

   Pharmacokinetics and Disposition 01 November 2005 Pages: 755 - 761

   

6. Changes to methadone clearance during pregnancy

   • Kim Wolff
   • Annabel Boys
   • Duncan Raistrick

   Pharmacokinetics and Disposition 01 November 2005 Pages: 763 - 768

   

7. Reliability of a modified medication appropriateness index in primary care

   • Lisbeth Bregnhøj
   • Steffen Thirstrup
   • Jesper Sonne

   Pharmacoepidemiology and Prescription 01 October 2005 Pages: 769 - 773

8. Off label and unlicensed drugs use in paediatric cardiology

   • M. Bajcetic
   • M. Jelisavcic
   • R. Gorodischer

   Pharmacoepidemiology and Prescription 08 September 2005 Pages: 775 - 779

9. Apolipoprotein E (APOE) and warfarin dosing in an Italian population

   • Hugo Kohnke
   • Maria Gabriella Scordo
   • Mia Wadelius

   Letter to the Editors 26 August 2005 Pages: 781 - 783

   

10. An evaluation of the World Health Organization problem-based pharmacotherapy teaching courses (based on the “Guide to Good Prescribing”), 1994–2001

    • Anthony Smith
    • Suzanne Hill
    • Mona Thambiran

    Letter to the Editors 21 September 2005 Pages: 785 - 786

11. Impact of clinical pharmacology on health care: Serbian experience

    • Slobodan M. Janković
    • Viktorija Dragojević-Simić
    • Dragan R. Milovanović

    Letter to the Editors 08 September 2005 Pages: 787 - 788

    

12. The year in therapeutics: Editors David J. Webb, Kenneth R. Paterson and David A. Flockhart

    • Michael Orme

    Book Review 08 September 2005 Pages: 789 - 789